Fueled by Mideast tensions, HUSA shares skyrocketed last week on high trading volume. Shares fall sharply Monday as easing tensions caused global oil prices to drop. Last Chance: See the "Power ...

HUSA, an oil and gas exploration and production company, appears to be a direct beneficiary of this uncertainty, as investors flock to energy stocks amid fears of disrupted global oil supply.

Houston American Energy Corp., an independent oil and gas company, engages in the acquisition, exploration, exploitation, development, and production of natural gas, crude oil, and condensate in ...

Last month Arcus reported top -line phase 2 results with the TIGIT drug that it said warranted taking it forward into a phase 3 programme, but so far there's no word from Gilead on a buy-in.

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s development product portfolio includes ...

Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination ...

Business Central CEO Simon Arcus told Ryan Bridge things will probably still fluctuate in coming years. He says there are often moments where things seem to improve, then sink back again.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...